PAD2- OPTIMIZATION OF AN HMOS NSAID PORTFOLIO FOLLOWING THE INTRODUCTION OF CELECOXIB
May 1, 1999, 00:00
10.1016/S1098-3015(11)70983-4
https://www.valueinhealthjournal.com/article/S1098-3015(11)70983-4/fulltext
Title :
PAD2- OPTIMIZATION OF AN HMOS NSAID PORTFOLIO FOLLOWING THE INTRODUCTION OF CELECOXIB
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)70983-4&doi=10.1016/S1098-3015(11)70983-4
First page :
Section Title :
Open access? :
No
Section Order :
159